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The development of SELEX (Selective Enhancement of Ligands by Exponential
Enrichment) provides a powerful tool for the search of functional oligonucleotides with
the ability to bind ligands with high affinity and selectivity (aptamers) and for the discovery
of nucleic acid sequences with diverse enzymatic activities (ribozymes and DNAzymes).
This technique has been extensively applied to the selection of natural DNA or RNA
molecules but, in order to improve chemical and structural diversity as well as for
particular applications where further chemical or biological stability is necessary, the
extension of this strategy to modified oligonucleotides is desirable. Taking into account
these needs, this review intends to collect the research carried out during the past years,
focusing mainly on the use of modified nucleotides in SELEX and the development
of mutant enzymes for broadening nucleoside triphosphates acceptance. In addition,
comments regarding the synthesis of modified nucleoside triphosphate will be briefly
discussed.
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INTRODUCTION
Nowadays, nucleic acids are not only considered as genetic information messengers or repositories.
New functions and applications of these molecules, like catalysis and molecular recognition have
emerged in the last 25 years (Klussmann, 2006), impacting different fields like: therapeutics
(Tei et al., 2015), target validation (Rodríguez et al., 2015), molecular biology (Lee et al., 2015),
diagnostics (Wandtke et al., 2015), and analytical chemistry (Li and Lu, 2009; Mascini, 2009;
Peinetti et al., 2015). The term “functional oligonucleotide” was coined in reference to these new
functions.
Although some examples of these “non-traditional” oligonucleotide activities can be found in
nature, as in the case of ribozymes, microRNAs and riboswitches (Li and Lu, 2009), a whole
set of catalytic (RNA: ribozymes, DNA: DNAzymes) and molecular recognition oligonucleotides
(aptamers) have been synthetically prepared, since they can be obtained using in vitro molecular
evolution techniques. This methodology merges a combinatorial chemistry approach with a
particular property of nucleic acids: amplification with the assistance of polymerases. This
procedure was simultaneously developed in three independent laboratories in 1990 (Ellington
and Szostak, 1990; Robertson and Joyce, 1990; Tuerk and Gold, 1990) and was denominated
SELEX (Systematic Evolution of Ligands by Exponential Enrichment). Since then, many different
variations of the technique were developed in order to achieve better selectivity and binding
constants, and simpler experimental conditions (Sun and Zu, 2015; Yüce et al., 2015).
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During the first years of aptamer development it was soon
understood that this functional oligonucleotides could emulate
monoclonal antibodies performance in diagnosis (Jayasena,
1999) and therapeutic (Schmid-Kubista et al., 2011) applications.
Additionally, aptamers have some advantages over antibodies:
they can be chemically synthesized without the assistance of
animals; are thermally stable and can be easily fold and unfold.
But also they have a major drawback (as DNAzymes and
ribozymes); they have short lives in biological fluids due to
the ubiquitous presence of endo and exonuclease activities.
The strategy to overcome this limitation was the same that
was employed in the development of antisense oligonucleotides
(Iannitti et al., 2014): the structural chemical modification.
Modified functional oligonucleotides could be obtained
according to two different strategies: post-selection modification
or via modified-SELEX (mod-SELEX) techniques (Figure 1).
The first approach has the advantage of dealing with natural
oligonucleotide chemistry, but as consequence of the delicate
relationship between structure and activity, post-selection
modification without losing activity demonstrated to be a hard
task in ribozymes (Pontiggia et al., 2010), DNAzymes (Robaldo
et al., 2014), or aptamers (Bouchard et al., 2010; Förster et al.,
2012).
Taking into account this drawback, early efforts were done
to modify the SELEX cycle in order to introduce modified
nucleotides (Figure 1). The first report of mod-SELEX was
done by Jayasena group (Lin et al., 1994) who succeeded in
FIGURE 1 | Schematic representation of the alternative routes to obtain modified functional oligonucleotides.
performing an in vitro selection of an RNA aptamer against
human neutrophil elastase (HNE) using 2′-aminopyrimidine
nucleotides. The resulting aptamer had a Kd of (6± 3) nM and a
half life in serum of (9.3 ± 1.8) h, greatly improving the half life
of the unmodified control sequence (4 min). Modifications at the
2′-position of the ribose moiety and phosphate internucleotide
linkage were usually introduced in the oligonucleotide structure
to enhance the chemical and biological stability (Figure 1).
In addition to stability, another important issue that drives
the chemical modification of functional oligonucleotides is the
augmentation of structural diversity. In this sense, one of the
earliest examples was the obtainment of a DNA anti-thrombin
aptamer using 5-pentinyl deoxyuridine by Toole group (Latham
et al., 1994). Although the modified aptamer showed a weaker
binding constant against thrombin compared to the natural
aptamer obtained by the same group (Bock et al., 1992), they
showed that the chemical structures of the modified and the
natural aptamers were different.
It should be remarked that mod-SELEX and post-selection
techniques are not excluding strategies as can be learned
from the commercial anti-VEGF165 aptamer. Janjic group
prepared a 2′-F-pyrimidine modified anti-VEGF165 aptamer
using a mod-SELEX approach (Ruckman et al., 1998) and
after the selection of the best sequence, 2′-OMe-ribopurine
nucleotides were introduced in some positions without losing
binding capacity [Kd = (49–130) pM]. This heavily modified
aptamer became lately the first example of a therapeutic
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aptamer approved by the FDA against ocular vascular disease,
Pegaptanib (Ng et al., 2006). In a variant of the mod-SELEX
strategy Mayer and colleagues (Toole et al., 2015) obtained
a modified aptamer against cycle 3 GFP (Kd = 18.4 nM)
using 5-ethynyl-2′-deoxyuridine triphosphate which was further
derivatized after polymerase amplification using click chemistry.
A similar strategy, termed SELMA (Selection with Modified
Aptamers), was used to generate DNA scaffolds containing
ethynyl deoxyuridine moieties that were glycosylated employing
glycan azides (Horiya et al., 2014). After selection of the most
antigenic clusterings of the glycan, the bound sequences were
amplified and reglycosylated to be used in the next selection step.
In the following sections the focus will be set on the
different modified triphosphate nucleosides used in in vitro
selection techniques but it should also be remarked that the
modified phosphoramidites (Figure 1) are also essential in order
to chemically prepare larger amounts of the modified functional
oligonucleotides.
Although comprehensive and recent reviews about the
different topics treated in this work are available (Diafa and
Hollenstein, 2015; Lapa et al., 2016), the main purpose of this
report is to connect all of them having in mind the application
of modified nucleotides to in vitro selection techniques, focusing
on recent related examples.
MODIFIED NUCLEOTIDES FOR SELEX
The design of useful modified nucleotides appropriate for mod-
SELEX has some restrictions that can be summarized in four
conditions (Perrin et al., 1999):
1. should not disturb the base pair interactions (Watson-Crick
and Hoogsteen);
2. must be substrates of the corresponding DNA or RNA
polymerases;
3. the introduction of the modified nucleotide must be efficient
at any position of the sequence;
4. the modified sequence must be a template for the
corresponding polymerases.
In addition to the excellent available reviews in this field (Keffe
and Cload, 2008; Hollenstein, 2012a; Kong and Bym, 2013) we
intend in this section to summarize the main chemical nucleotide
modifications that have been used for in vitromolecular selection,
paying special attention to cases not reviewed earlier.
Regarding the modified nucleotides that have been used in
SELEX, most examples are related to structural modifications
of pyrimidine derivatives in three different positions: the α-
phosphate, the 2′- and C5-positions (Figure 2). As consequence
of the extraordinary sensitivity to degradation of RNA
oligonucleotide libraries, the first mod-SELEX examples
were motivated by the improvement of oligonucleotide stability
against RNases, by substitution of the of 2′-hydroxyl of ribose
by other functionalities. As mentioned above, the first reported
example was developed by Jayasena group (Lin et al., 1994) who
used 2′-aminouridine and 2′-aminocytidine triphosphates (3,
Figure 2) to obtain a modified RNA aptamer against Human
Neutrophil Elastase (HNE). When it was incubated in human
serum and human urine, the HNE modified aptamer showed
an enhanced stability compared to the unmodified sequence.
Although the 2′-aminopyrimidine modification was also used
to obtain a modified aptamer against the vascular permeability
factor (VPF), the vascular endothelial growth factor (VEGF;
Green et al., 1995) and the basic fibroblast growth factor (Jellinek
et al., 1995), this modification was no longer used, probably
due to the difficulties in the triphosphate preparation and the
destabilizing effect of 2-amino groups in RNA duplexes. It was
noticed that when the 2′-amino modification was compared to
the 2′-fluoro analogs (4, Figure 2) for the same target, as in the
case of the keratinocyte growth factor aptamer (Pagratis et al.,
1997), both modifications have similar nuclease resistance but
fluoro analogs have better affinities (two orders). As additional
feature, compared to amine groups, 2′-fluoro modification
does not require protection-deprotection steps along the
oligonucleotide solid phase synthesis, reasons that could partially
explain the popularity of this modification (Dupont et al., 2010;
Svobodova et al., 2013).
Modified 2′-O-methylnucleotides (5, Figure 2) have also been
used to get an aptamer against VEGF (Burmeister et al.,
2005). Keefe and coworkers identified reaction conditions that
allowed the incorporation of significant amounts of 2′-OMe-
deoxyguanosine triphosphate into transcripts in the presence
of ribosyl triphosphate. Guanosine positions must be finally
checked to confirm the presence of natural or modified
nucleotide. The obtained 23 nucleotide long aptamer (ARC245),
showed a Kd of 2 nM and a fully modified structure which avoids
degradation for at least 96 h in plasma. In the same sense, Li
group (Friedman et al., 2015) recently developed a fully modified
aptamer against Staphylococcus aureus Protein A (SpA) using 2′-
F-deoxyguanosine, 2′-OMe-adenosine, -cytidine, and -uridine,
an RNA library and a mutant (LAR) T7 RNA polymerase that
circumvent the previously mentioned inconvenience of using
small amounts of natural ribonucleotides.
A promising field is the aptamer obtainment using nucleotides
with fully modified sugar moieties. Chaput and colleagues (Yu
et al., 2012) succeeded in the preparation of a Threose Nucleic
Acid (TNA) aptamer against human thrombin (Kd = 0.2–0.9
µM) with the assistance of an engineered variant of 9◦N DNA
polymerase.
Holliger and colleagues (Taylor and Holliger, 2015; Taylor
et al., 2015) reported the preparation of four XNAzymes
(catalyst from synthetic genetic polymers, XNA) based on
four different sugar backbones: Arabino Nucleic Acids (ANA),
2′-Fluoroarabino Nucleic Acids (FANA), Hexitol Nucleic
Acids (HNA) and Cyclohexene Nucleic Acids (CeNA). Mutant
polymerases D4k for ANA and FANA, 6G12 for CeNA, and 6G12
I512L for HNA were employed for preparing the XNA libraries.
Under these conditions RNA endonuclease (ANA, FANA, HNA,
CeNA), RNA ligase and XNA ligase (FANA) activities were
obtained.
Another position that has been modified with the objective of
increasing nuclease resistance is the α-phosphate of nucleoside
triphosphates. Ellington and coworkers (Jhaveri et al., 1998)
obtained an anti basic fibroblast growth factor (bFGF) RNA
aptamer in which all internucleotide linkages were modified
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FIGURE 2 | Modified nucleoside triphosphates used in SELEX experiments. References: 1: (Jhaveri et al., 1998; Somasunderam et al., 2010; Higashimoto
et al., 2013); 2: (Lato et al., 2002); 3: (Lin et al., 1994; Green et al., 1995; Jellinek et al., 1995); 4: (Svobodova et al., 2013; Dupont et al., 2010); 5: (Burmeister et al.,
2005); 6: (Pagratis et al., 1997); 7: (Friedman et al., 2015); 8: (Latham et al., 1994); 9: (Li et al., 2008); 10: (Vaught et al., 2010; Ochsner et al., 2013, 2014); 11:
(Tarasow et al., 1997); 12: (Battersby et al., 1999); 13: (Vaish et al., 2003); 14: (Masud et al., 2004; Shoji et al., 2007); 15: (Santoro et al., 2000; Sidorov et al., 2004);
16: (Wiegand et al., 1997); 17: (Hollenstein et al., 2009); 18: (Imaizumi et al., 2013); 19: see 9; 20: (Hollenstein et al., 2009); 21: (Sidorov et al., 2004); 22: (Hollenstein
et al., 2009); 23: (Liu et al., 2010); 24: (Kasahara et al., 2013); 25: (Minikawa et al., 2008).
with phosphorothioates (1, Figure 2). Although the yield of
phosphorothiolated RNA following in vitro transcription and
purification was low, it was enough for selection experiments
and a 13 nucleotide consensus sequence with a Kd of 1.8
nM for bFGF was selected. Using the same modification
Gorenstein and coworkers (Somasunderam et al., 2010) obtained
a thiophosphate-modified DNA aptamer against the hyaluronic
acid binding domain (HABD). In this case, all deoxyadenosine
residues (with the exception of primers) were replaced by
deoxyadenosine thiophosphates in the Sp configuration. More
recently, Yamagishi and coworkers (Higashimoto et al., 2013)
selected phosphorothioate-modified aptamers directed against
advanced glycation end products (AGEs–thioaptamers) using
a mixture of 2′-deoxyadenosine-5′-O-(1-thiotriphosphate)
(dATP(αS)), 2′-deoxythymidine-5′-O-(1-thiotriphosphate)
[dTTP(αS)] and a mixture of deoxycytidine and deoxyguanosine
triphosphates. The obtained aptamers had Kd in the low
nanomolar range. Another feasible modification in the α-
phosphate moiety of the nucleotides is the replacement of
oxygen by a borohydride group (boranophosphate, 2, Figure 2).
Burke and coworkers (Lato et al., 2002) explored the use of
uridine (bU) or guanosine (bG) 5′-(α-P-borane) in a SELEX
process against ATP. Even if bU and bG are compatible with the
selection process, when they were introduced in natural aptamer
structures usually diminished or eliminated target recognition.
Although the 2′-position and the α-phosphate nucleotide
modifications mainly pursue the increase of oligonucleotides
stability, another important aspect of SELEX is the expansion
of the chemical diversity of the nucleotide moiety. It was
reasoned that a set of complementary functional groups, not
originally available in the nucleotide structures, will enhance
the chances of molecular recognition or catalytic phenomenon.
In this regard, 5-position of pyrimidine, particularly uridine
and deoxyuridine, was the most frequent modification option.
Functional groups present in the 5-pyrimidine position could
be classified in three main sets: hydrophobic, acid/base and
others (boronic). In the first subset we can find examples such
as compounds 8, 9, and 10 in Figure 2. Toole and coworkers
(Latham et al., 1994) prepared DNA aptamers against thrombin
using 5-(1-pentinyl)-2′-deoxyurindine (8, Figure 2) with Kd in
the range of 400–1000 nM. Wang and coworkers (Li et al., 2008)
introduced hydrophobic structures (9, Figure 2) in aptamers
against fibrinogen. In a systematic way, Eaton and coworkers
(Vaught et al., 2010) first and Janjic and coworkers later (Ochsner
et al., 2014), explored the use of a set of hydrophobic moieties
connected to the 5-position of deoxyuridine by an amide group
(10, Figure 2). In Eaton’s work an exploration of the best
polymerases that accept the modified nucleotides as substrates
was done, finding that the OD XL and D.Vent(exo-) were able to
incorporate the modified deoxyuridine triphosphate derivatives
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with similar or better yields than with thymidine triphosphate. In
this case the selected targets were the tumor associated calcium
signal transducer 2 (TACSTD2) and the tumor necrosis factor
receptor super family member 9 (TNFRSF9). In the first case
benzyl and isopropyl moieties were used giving aptamers with
Kds in the nM range. In the second case, where previous DNA
selections failed, the benzyl moiety afforded an aptamer with a
Kd of 100 nM.
As previously commented, Janjic and coworkers also explored
the use of hydrophobic modifications. In this case the objective
was to develop methods for the systematic isolation of aptamers
that bind to different epitopes of proteins, allowing efficient pair-
wise screening of multiple ligands (Ochsner et al., 2014; Rohloff
et al., 2014). These aptamers, named slow off-rate modified
aptamers (SOMAmer) were prepared using a benzyl moiety
linked to the uracil by an amide group and were directed against
human proteins like: ANGPT2, TSP2, CRDL1, MATN2, GPVI,
C7, and PLG, some of them indicators of cardiovascular risk. The
equilibrium dissociation constants ranged from 0.02 to 2.7 nM.
Considering now 5-pyrimidine nucleotide modifications with
acid/base activity, a functional group usually present in this
position is amine (or ammonium). Eaton and coworkers
(Tarasow et al., 1997) synthesized a 5-pyridylmethylcarboxamide
uridine (11, Figure 2) for the obtainment of a ribozyme
with moderate dielsalderase activity (Diels Alder carbon-
carbon bond formation). Benner and coworkers (Battersby
et al., 1999) synthesized 5-(3′′-aminopropynyl)-2′-deoxyuridine
triphosphate (12, Figure 2) which was used to replace thymidine
nucleotide in a SELEX process, with the assistance of the
Vent DNA polymerase, against the ATP molecule as target.
The consensus sequences were examined to determine if they
matched or not the original Szostak sequence (Huizenga and
Szostak, 1995), finding significant resemblance with the “Lin-
Patel-Huizenga-Szostak motif ” (Battersby et al., 1999).
Regarding the existence of modified moieties found in RNA
of biological sources, post-transcriptional modifications are
implicated in catalytic or molecular recognition events (Limbach
et al., 1994; Helm and Alfonzo, 2014). Although moieties with
a positive charge are naturally rare, some examples are known,
like in the case of archaeosine (Gregson et al., 1993), a modified
purine that has a positive charge at physiological pH. This
fact inspired McLaughlin and coworkers (Vaish et al., 2003)
who used 5-(3-aminopropyl) uridine (13, Figure 2) to obtain
an RNA aptamer against ATP. The resulting sequence had a
Kd of 1.08mM with several of the modified uridines critical
for target recognition. Following the same concept, Sawai and
coworkers (Masud et al., 2004) used the 5′-triphosphate of 5-N-
(6-aminohexyl)carbamoylmethyl-2′-deoxyuridine (14, Figure 2)
for the selection of a DNA aptamer (Kd = 4.9 µM) against
sialyllactose, an oligosaccharide with a carboxy group that
appears to be an essential receptor component of many animal
viruses from different families, such as influenza A and C
viruses. The same modified pyrimidine was lately used by this
research group to develop an aptamer against the (R)-isomer of
Thalidomide (Shoji et al., 2007) with a Kd of 1 µM.
Other nitrogen containing substituents were evaluated. Barbas
and coworkers (Santoro et al., 2000) obtained by in vitro
evolution a DNAzyme with RNase activity carrying an imidazolyl
moiety at the 5-position of deoxyuridine (15, Figure 2). The
DNAzyme has a minimum core of twelve nucleotides including
three imidazole-functionalized nucleotides and requires µM
concentration of Zn2+ and mM of Mg2+ and Na+ for being
active. Lately, Williams and coworkers (Sidorov et al., 2004)
used a combination of the 5-imidazolyl-modified deoxy uridine
triphosphate (15, Figure 2) plus a 7-aminopropynyl modified
7-deaza-deoxyadenosine triphosphate analog (12, Figure 2),
for the selection of a DNAzyme with RNA cleavage activity
independent of divalent metal requirements. Following with
the development of modified functional oligonucleotides with
catalytic activity, Eaton and coworkers (Wiegand et al., 1997)
used 5-imidazolyl uridine triphosphate analog (16, Figure 2)
for the preparation of a ribozyme with amide-bond formation
activity, pushing the hypothesis of the expansion of nucleic acid
catalytic activity. With the same objective, Perrin and coworkers
(Hollenstein et al., 2009) used a simultaneous combination of
8-histaminyl-deoxyadenosine (21, Figure 2), 5-guanidinoallyl-
deoxyuridine (17, Figure 2) and 5-aminoallyl-deoxycytidine
(20, Figure 2) triphosphates in an in vitro selection of a
heavily modified metal2+ free DNAzyme with RNase activity.
Pursuing a similar goal, Williams and coworkers (Sidorov
et al., 2004) prepared and used a 3-(aminopropynyl)-7-deaza-
deoxyadenosine triphosphate (21, Figure 2). In a recent example,
Silverman and colleagues (Zhou et al., 2016) showed that
the introduction of protein-like residues (5-thymidine primary
alcohol, amine or carboxyl group) allowed the selection of
modifiedDNAzymes with amide hydrolytic activity that was until
then an elusive enterprise.
Sugimoto and coworkers (Imaizumi et al., 2013) prepared
a (E)-5-(2-(N6-adeninyl)ethyl))carbamylvinyl)deoxyuridine
triphosphate (23, Figure 2) that was used to obtain a modified
DNA aptamer against camptothecin, a quinoline alkaloid
that inhibits topoisomerase I. In this case, the modified
aptamer showed a higher affinity constant than the unmodified
captothecin aptamer, illustrating the hypothesis that additional
aptamer functionalization can improve binding performance.
Returning to modified aptamer examples, Wang and
coworkers (Li et al., 2008) prepared a boronic acid 5-modified
thymidine triphosphate (19, Figure 2) with the aim of improving
aptamer binding to glycoproteins (fibrinogen as model), based
on the known ability of boron to coordinate glycol groups.
The boronic acid modified aptamers selected against fibrinogen
had a Kd in the low nM range, while aptamers prepared with
natural nucleotides had Kds ca. 5 µM, confirming the proposed
hypothesis.
Ito and coworkers (Liu et al., 2010) prepared a
photoresponsive N6-azobencene-adenosine triphosphate
(23, Figure 2) for the selection of a modified RNA aptamer
against hemin with catalytic activity as peroxidase. The
aim of this modification was the photocontrol of the
recognition event and consequently of the catalytic activity.
The visible and UV irradiation of the obtained modified
aptamer controlled the cis-trans azobencene isomerization,
which modified the hemin-aptamer catalytic ability as
peroxidase.
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Finally, some modifications in the ribose/deoxyribose
moieties have also been explored. Kuwahara and coworkers
(Kasahara et al., 2013) explored the use of 2′-O,4′-C-methylene-
bridged bicyclic ribonucleotides (24, Figure 2) for the selection
of DNA aptamers against human thrombin. The aptamers were
selected by capillary electrophoresis-SELEX (CE-SELEX) and
had Kd in the low nM range. Matsuda and coworkers (Minikawa
et al., 2008) used 4′-thioribonucleotides (25, Figure 2) for
the selection of an RNA aptamer against human α-thrombin.
The optimization of the SELEX conditions for the use of the
four modified nucleotides (25, Figure 2) included the use of
additional amounts of ATP and GTP and the assistance of
mutant polymerases. The highly-modified 4′-thioRNA aptamer
was also post-selection fully modified, having a Kd of 29.6 nM.
All the examples of modified nucleotides described so
far have been successfully used in SELEX processes finally
obtaining functional oligonucleotides. However, some examples
of modified nucleotides, accepted by mutant polymerases and
not applied yet to SELEX, have also been described. Just to
mention two examples, Hollenstein (2012b) has described a
set of 5-modified deoxyuridine, with moieties designed for
organocatalysis (26, Figure 3). These modified nucleotides were
substrates of Ven (exo-), Pwo DNA and E. coli Klenow
fragment polymerases. More recently, Perrin and coworkers
(Liu et al., 2015) reported the preparation of 5-aminomethyl
deoxyuridine triphosphate derivatives (27, Figure 3) modified
mainly with aromatic moieties. The authors successfully used
all modified triphosphates as substrates of the Vent (exo-)
polymerase.
A mention to L- aptamers (Spiegelmers) will also be included.
Although they were not strictly obtained using modified
nucleoside triphosphates (Eulberg et al., 2006), the final result
of this variant of the SELEX method is a fully modified L-
aptamer. This technique has been applied when the enantiomer
of the target was synthetically available, as in the case of peptides
(Yatime et al., 2015) or RNA structures (Sczepanski and Joyce,
2013).
Another interesting approach is the use of the genetic alphabet
expansion. Hirao and colleagues (Kimoto et al., 2013) have
described the first example of modified aptamers against human
VEGF-165 (Kd = 0.62 nM) and interferon-γ (Kd = 0.038 nM)
using the four natural DNA bases plus an additional synthetic
base pair in an expanded alphabet strategy, naming the technique
as Expanded-SELEX (ExSELEX; Kimoto et al., 2016).
MODIFIED NUCLEOSIDE TRIPHOSPHATE
SYNTHESIS
When modified nucleoside triphosphates (NTPs) for in vitro
selection techniques are needed they have to be synthesized,
since only few of them are commercially available. Therefore, for
the safe of completion, a brief summary of the main methods
developed for this purpose are herein included.
The regioselective modification of nucleosides is a
cumbersome goal due to their polyfunctional structure and
in particular an effective and general methodology for the
synthesis of NTPs is still a challenge without a proper solution.
In addition, NTPs are polycharged and unstable molecules,
characteristics that make difficult the work up processes
associated with their purification.
The available protocols for NTPs synthesis were extensively
reviewed (Burgess and Cook, 2000; Hollenstein, 2012a; Kore and
Srinivasan, 2013), and here will be only briefly mentioned.
One of the pioneer methods was the one carried out
by Ludwig (Ludwig, 1981) based on the regioselective 5′-
phosphorylation designed by Yoshikawa (Yoshikawa et al., 1967).
It consists in the one pot reaction of an unprotected nucleoside
and phosphorus oxychloride using trimethyl phosphate as
solvent. The reactive 5′-phosphorodichlorate intermediate is
further treated with bis-tributylammonium pyrophosphate to
generate a cyclic triphosphate which is finally hydrolysed to the
corresponding NTP. This process is not suitable for modified
nucleosides and in addition involves difficult purification
FIGURE 3 | Modified nucleoside triphosphates accepted by modified polymerases but not yet used in SELEX protocols.
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processes due to the presence of secondary products. A recent
contribution to this strategy (Korhonen et al., 2015) propose
the use of tris{bis(triphenylphosphoranylidene) ammonium}
(PPN) pyrophosphate as an alternative to the hygroscopic
alkylammonium salts.
An alternative method developed by Ludwig and Eckstein
(Ludwig and Eckstein, 1989) is still nowadays widely applied
for the preparation of NTPs. It is also a one pot route
but the nucleoside must be properly protected owing to the
lack of regioselectivity of the process. This route involves the
attack of salicyl phosphorochlorite to afford the corresponding
5′-phosphite derivative. The subsequent addition of bis-
tributylammonium pyrophosphate produces the key cyclic
phosphite intermediate, which is then oxidized in situ to yield
the resultant NTP. Although the interfering nucleosidic functions
need to be protected, the purification protocols are simpler since
the presence of other polycharged species is minimized.
Another strategy, designed by Caton-Williams et al. (Caton-
Williams et al., 2011a,b, 2013), also makes use of the salicyl
phosphorochloridite reagent, but through and altered route.
In this synthetic scheme the phosphitylating agent is first
treated with pyrophosphate in DMF to generate the actual
phosphitylating reagent that regioselectively reacts with the 5′-
hydroxyl of an unprotected nucleoside to produce a similar cyclic
intermediate to the one formed in the Ludwig-Eckstein strategy.
Finally, the corresponding NTP is obtained by traditional
iodine oxidation and hydrolysis. After performing a simple
ethanol precipitation, the crude product can be directly used as
polymerases substrate.
Many other different approaches have been explored in the
search of a universal and efficient route for the preparation
of NTPs, some of them employ nucleoside phosphites,
phosphoramidites, diphosphates or displacement of 5′-O-
leaving groups by triphosphate. A complete revision of these
methods has already been reviewed (Burgess and Cook, 2000;
Kore and Srinivasan, 2013).
The environmental friendly approaches offered by biocatalysis
and biotransformations give an intestering alternative to the
chemical preparation of NTPs since they provide regioselective
reactions using mild conditions (Staffan, 2005). This process
involves three steps being the first one catalyzed by specific
nucleoside kinases. Therefore, alternative enzymatic procedures
for the preparation of nucleoside monophosphates are relevant
and have been recently reviewed (Iglesias et al., 2015).
As for chemical approaches, the biocatalyzed syntheses do not
provide a general and efficient method for NTPs preparation and
the appropriate route for each case has to be explored specifically.
POLYMERASES FOR MODIFIED
NUCLEOTIDES
The increasing number of nucleotide analogs used for the
development of functional oligonucleotides demands the access
to polymerases with an expanded substrate repertoire. Over
the years natural polymerases have been tested for their ability
to accept unnatural nucleotides and many directed evolution
experiments have been carried out to achieve this goal being
these works properly reviewed in several papers (Henry and
Romesberg, 2005; Lauridsen et al., 2012; Walsh and Beuning,
2012; Chen and Romesberg, 2014; Laos et al., 2014). A summary
of polymerases evolved to accept modified nucleotides can be
seen in Table 1.
POLYMERASES FOR NUCLEOTIDES
BEARING SUGAR MODIFICATIONS
In the 1990s Aurup et al. demonstrated that wild type T7 RNA
polymerase could accept 2′-fluoro-CTP, 2′-fluoro-ATP, 2′-fluoro-
UTP, and 2′-amino-UTP as substrates in transcription reactions.
Results showed that short templates could be transcribed to
full-length RNA products in the presence of these modified
nucleotides, although higher affinity was observed for the 2’-
amino analogs (Aurup et al., 1992). This enzyme was also found
to be capable of synthesizing quimeric nucleic acids composed
of ribo and deoxyribonucleotides and of incorporating 2′-O-
methylnucleotides in various positions (Conrad et al., 1995).
Since then, many directed evolution experiments have been
performed to improve T7 RNA polymerase substrate repertoire
and processivity. Rational design led to a T7 RNA polymerase
bearing the Y639F mutation, which was able to synthesize
transcripts with 2′-fluoro, 2′-amino, 2′-O-methylpyrimidines
and 2′-deoxy-2′-thio-CTP more efficiently than the wild type
(Raines and Gottlieb, 1998; Padilla and Sousa, 1999). A double
mutant (Y639F:H784A) was later reported that showed improved
use of 2′-O-methyl and 2′-azido pyrimidines as substrates
(Padilla and Sousa, 2002). Using the autogene selection method
many other variants were reported with better utilization
of 2′-substitued NTPs (Chelliserrykattil and Ellington, 2004).
Interestingly, mutations previously shown to increase the
thermal tolerance of T7 RNA polymerase can also increase the
activity of mutants with expanded substrate range (Meyer et al.,
2015). T7 RNA polymerase was also tested for its ability to accept
2′-C-branched NTPs. Wild type enzyme was able to perform the
reaction with 2′-α-hydroxymethyl-UTP while the Y639F mutant
was unable to use any of the substrates (Pavey et al., 2004). In
another work, the wild type enzyme was capable of synthesizing
4′-thioRNA using 4′-thioUTP and 4′-thioCTP (Kato et al., 2005).
Regarding accessible enzymes, it is worth mentioning
that many commercially available DNA polymerases such as
SequiTherm, Tht, AmpliTaq FS (exo-), Pfu (exo-), Vent (exo-),
and deep Vent (exo-) as well as the human DNA polymerases
α and γ, were qualified to accept 2′-fluoro-modified NTPs (Ono
et al., 1997; Richardson et al., 2000).
Directed evolution efforts have also focused on the widely
used Taq DNA polymerase to improve 2′-modified nucleotides
recognition. Several variants of this enzyme have been identified
to incorporate ribonucleotides more efficiently than the wild
type (Suzuki et al., 1996; Patel and Loeb, 2000; Ogawa et al.,
2001; Patel et al., 2001) whereas Taq DNAP AA40 was able to
incorporate ribonucleotides as well as 2′-azido and 2′-fluoro
NTPs (Ong et al., 2006). Stoffel fragment (Sf) DNA polymerase, a
proteolytic fragment of Taq DNA polymerase, was also subjected
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TABLE 1 | Polymerases evolved to accept modified nucleotides.
Polymerase Mutations Activity References
T7 RNAP (RGFH) (Y639F) Incorporates with 2′-F, 2′-amino, 2′-OMe pyrimidines,
2′-deoxy-2′-thio CTP
1;2
T7 RNAP(RGFA) (Y639F:H784A) Synthesizes transcripts containing 2′-OMe pyrimidines, 2′-azidoU
or 2′-azidoC
3;4;5
T7 RNAP (VRS) (G542V:H784S:H772R) Incorporates 2′-F-pyrimidines 5
T7 RNAP (RGVG, E593G, V685A) (Y639V:H784G:E593G:V685A) Incorporates 2′-OMe pyrimidines 5
T7 RNAP (RGLH, A255T) (Y639L:A255T) Incorporates 2′-F pyrimidines, 2′-OMe pyrimidines 5
Taq DNAP (I614K) Incorporates rNTPs more efficiently than wild type 6;7
Taq DNAP (I614N:L616I) Incorporates rNTPs more efficiently than wild type 6;7
Taq DNAP (A661E) Incorporates rGTPs more efficiently than wild type 8;9
Taq DNAP AA40 (E602V:A608V:I614M:E615G) RNAP and RT activity. Incorporates rNTP, 2′-azido-NTP and
2′-F-NTP
10
Sf DNAP R1 (K531E:A597T:A600T:W604G:A608S:
L609V:I614T:E615G)
Incorporates rNTPs more efficiently than wild type 11
Sf DNAP R2 (A597T:E615G) Incorporates rNTP substrates more efficiently than wild type 11
Sf DNAP R3 (A597T:W604R:L605Q:I614T:E615G) Incorporates rNTP substrates more efficiently than wild type 11
Sf DNAP M19 (I614E:E615G) Incorporates 2′-O-methylNTP, rNTP, 2′-amino-NTP, 2′-azido-NTP,
2′-F-NTP
12;13
Kf DNAP (I709F) Incorporates rNTPs more efficiently than wild type 14
TgoT DNAP C7 (TgoT:E654Q:E658Q:K659Q:V661A:
E664Q:Q665P:D669A:K671Q:T676K:
R709K)
Replication of DNA CeNA and LNA 15
TgoT DNAP D4K (TgoT:L403P:P657T:E658Q:K659H:
Y663H:E664K:D669A:K671N:T676I)
Replication of DNA using ANA, or FANA 15
TgoT DNAP 6G12 (TgoT:V589A:E609K:I610M:K659Q:
E664Q:Q665P:R668K:D669Q:K671H:
K674R:T676R:A681S:L704P:E730G)
Replication of DNA using HNA 15
TgoT DNAP RT521 (TgoT:E429G:I521L:K726R) RT activity for oligonucleotides containing HNA, ANA, and FANA 15
TgoT DNAP RT521K (RT521:A385V:F445L:E664K) RT activity for oligonucleotides containing CeNA and LNA 15
Taq DNAP M1 (G84A:D144G:K314R:E520G:F598L:
A608V:E742G)
Replicates templates containing abasic sites, cis-syn cyclobutane
pyrimidine dimer, or 5-nitroindole. Incorporates 7-deaza-dGTP,
Rhodamine-5-dUTP, Biotin-16-dUTP, Fluorescein-12-dATP.
16
Taq DNAP (M444V:P527A:D551E:E832V) Accepts nucleotides with nonstandard hydrogen bond patterns 17
Taq DNAP (N580S:L628V:E832V) Accepts nucleotides with nonstandard hydrogen bond patterns 17
Tth and Taq DNAP chimera 5D4 (V62I:Y78H:T88S:P114Q:P264S:
E303V:G389V:E424G:E432G:E602G:
A608V:I614M:M761T:M775T)
Forms and extends d5NI and d5NIC self-pairs and heteropairs
with all four bases. Extends HBA pairs such as Pyrene: abasic
site, d5NI: abasic site, and ICS:7AI
18
Sf DNAP P2 (F598I:I614F:Q489H) Forms and extends DNA bearing ICS base pairing. 19
Pfu DNAP E10 (Pfu(exo-):V93Q:V337I:E399D:
N400D:R407I:Y546H)
Accepts Cy3-dCTP and Cy5-dCTP as substrates. 20
Taq DNAP M1 (G84A:D144G:K314R:E520G:F598L:
A608V:E742G)
Accepts phophorothioates. Alllows a full substitution of dNTPs
with αS dNTPs.
16
Pfu DNAP Q484R + split Incorporates γ-phosphate-O-linker dabcyl derivatives. 21
DNAP, DNA polymerase; RNAP, RNA polymerase; NTP, nucleoside triphosphate; CeNA, cyclohexenyl nucleic acid; LNA, locked nucleic acid; ANA, arabino nucleic acid; FANA, 2′-F-
arabino nucleic acid; HNA, 1,5-anhydrohexitol nucleic acid; d5NI, 5-nitroindole; d5NIC, 5-nitroindole-3-carboxamide; ICS, isocarbostyril; 7AI, 7-azaindole. Refrences: 1 (Padilla and
Sousa, 1999); 2 (Raines and Gottlieb, 1998); 3 (Padilla and Sousa, 2002); 4 (Burmeister et al., 2006); 5 (Chelliserrykattil and Ellington, 2004); 6 (Patel and Loeb, 2000); 7 (Patel et al.,
2001); 8 (Suzuki et al., 1996); 9 (Ogawa et al., 2001); 10 (Ong et al., 2006); 11 (Xia et al., 2002); 12 (Fa et al., 2004); 13 (Schultz et al., 2015); 14 (Shinkai et al., 2001); 15 (Pinheiro et al.,
2012); 16 (Ghadessy et al., 2004); 17 (Laos et al., 2013); 18 (Loakes et al., 2009); 19 (Leconte et al., 2005); 20 (Ramsay et al., 2010); 21 (Hansen et al., 2011).
to directed evolution obtaining the variants Sf R1, Sf R2 and Sf
R3 with an increased efficiency to incorporate ribonucleotides
(Xia et al., 2002), and Sf M19 that could also accept 2′-O-methyl
NTP, 2′-amino-NTP, 2′-azido-NTP and 2′-F-NTP as substrates
(Fa et al., 2004). A recent study improved the understanding
of the mutational origins of 2′-modified substrate recognition,
and also identified Sf M19 as the best candidate for further
engineering (Schultz et al., 2015). The Klenow fragment
(Kf), a proteolytic fragment of E. coli DNA polymerase I,
bearing one mutation (I709F), presented better incorporation
of ribonucleotides to the product than the wild type
(Shinkai et al., 2001).
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Another interesting finding regarding 2′-modified nucleotides
was the ability to add 2′-C-methyl analogs into RNA by a hepatitis
C virus RNA polymerase. Hepatitis C virus nonstructural protein
5B (HCV NS5B) accepted 2′-C-methyl-ATP and 2′-C-methyl-
CTP as substrates while mutant NS5B155 incorporated the
modified nucleotides more efficiently (Carroll et al., 2003;
Dutartre et al., 2006).
Enzymatic polymerization using LNA nucleotides was
reported using many different polymerases. First, the group of
Wengel (Veedu et al., 2007) reported that Phusion High-Fidelity
DNA polymerase had the capacity of adding up to three LNA-
TTPs and up to eight consecutive LNA-ATPs. Later, results
showed that 9◦NmTM DNA polymerase presented this activity
as well, and was able to read across LNA residues in the template.
In addition, T7 RNA polymerase was capable of transcription
incorporating LNA-ATPs as substrates and also full length RNA
transcripts were obtained when LNA and DNA templates were
involved (Veedu et al., 2008). In another work, it was observed
that using higher concentrations of KOD Dash, KOD (exo-) and
Vent (exo-) DNA polymerases led to higher yields of full length
products bearing LNA modifications (Kuwahara et al., 2008).
Several DNA polymerases were tested for their ability
to synthesize 2′-deoxy-2′-fluoro-β-D-arabino nucleic acids
(FANA). Experiments revealed that family B polymerases like
Deep Vent (exo-), 9◦Nm, Therminator and Phusion High-
Fidelity were able to incorporate all four FANA analogs to
yield full length products (Peng and Damha, 2007). A later
investigation, proposed the development of polymerases that
could synthesize Xeno nucleic acids (XNA, nucleic acids carrying
different types of synthetic sugars) from a DNA template and
polymerases that could reverse transcribe XNA back into DNA.
Using compartmentalized self-tagging (CST) selection from a
library of TgoT DNA polymerase, they obtained TgoT mutants
that were able to replicate DNA using cyclohexenyl nucleic
acids (CeNA), locked nucleic acids (LNA), arabino nucleic
acids (ANA), 2′-fluoroarabinonucleic acids (FANA) and 1,5-
anhydrohexitol nucleic acids (HNA) as substrates. By saturation
mutagenesis based on statistical correlation analysis (SCA) and
ELISA-like screening they evolved TgoT into variants capable of
reverse transcription of templates containing HNA, ANA, FANA
CeNA, and LNA (Pinheiro et al., 2012).
Recently, Holliger and co-workers (Cozens et al., 2015)
engineered the polymerase TGLLK (TgoT: Y409G, I521L, F545L,
E664K), which proved to be effective at fully replacing purine
dNTPs and NTPs with their respective 3′-deoxy or 3′-O-methyl
analogs with defined 2′-5′ linkages allowing template-directed
synthesis and reverse transcription of oligonucleotides with
mixed 2′-5′/3′-5′ backbone linkages, expanding the repertoire for
future in vitro evolution experiments.
POLYMERASES FOR NUCLEOTIDES
BEARING NUCLEOBASE MODIFICATIONS
Different thermostable DNA polymerases were tested using
C5-substituted pyrimidines as substrates. Family A DNA
polymerases, such as Taq, Tht and Thermosequenase, were able
to accept propynyl dUTP, dUTP, and methyl dCTP whereas
family B DNA polymerases, such as Pwo, Pfu, Vent (exo-), Deep
Vent (exo-), were able to incorporate 7-amino-2,5-dioxaheptyl
dUTP, 7-amino-2,5-dioxaheptyl dCTP, propynyl dUTP, and
methyl dCTP (Kuwahara et al., 2003). Vent (exo-), Pwo and
Kf DNA polymerases were also able to use NTPs carrying urea,
proline, and sulfonamide groups in the C5 position (Hollenstein,
2012b). DNA molecules containing 5-vinyl-dUTP, 5-vinyl-
dCTP, or 7-deaza-7-vinyl-dATP were prepared by polymerase
incorporation using Pwo, Vent (exo-), and KOD XL DNA
polymerases (Macˇková et al., 2014).
KOD Dash DNA polymerase was used to perform SELEX
of sialyllactose-binding DNA aptamers composed of several
modified TTPs bearing a positively-charged amino group at the
C5 position (Masud et al., 2004). Later, it was also showed the
ability to successfully accept dUTP bearing different aminoacids
at the C5 position (Kuwahara et al., 2006). Useful dCTP analogs
for aptamer discovery via SELEX bearing a 5-(N-substituted-
carboxamide) functional group were found to be suitable
substrates of KOD DNA polymerase (Rohloff et al., 2015).
Directed evolution of Taq DNA polymerase led to more
efficient enzymes that could bypassed blocking lesions such as
an abasic site, a thymidine dimer or the base analog 5-nitroindol
(Ghadessy et al., 2004; Loakes et al., 2009), and variants that could
accept nucleotides with nonstandard hydrogen bond patterns
therefore allowing the expansion of the genetic alphabet (Laos
et al., 2013).
Using directed short-patch compartmentalized self-
replication (spCSR) and the widely used fluorescent dye
label Cy3-dCTP and Cy5- dCTP as substrates, a variant of Pfu
DNA polymerase that was able to amplify double stranded DNA
fragments incorporating these analogs was obtained (Ramsay
et al., 2010).
Recent studies (Wyss et al., 2015) involving the ability to
amplify DNA adducts showed that a mutant of KlenTaq DNA
polymerase (KTqM747K), was able to incorporate an artificial
nucleotide, BenziTP, opposite to a DNA alkylation adduct with
high selectivity. In this way, the artificial nucleotide functions as
a marker for the adduct in the original template being useful to
investigate DNA damage levels.
POLYMERASES FOR NUCLEOTIDES
BEARING TRIPHOSPHATE
MODIFICATIONS
Nucleosides carrying 5′-O-(1-thiotriphosphate) moieties
(NTP(αS)) are the most employed triphosphate modified
substrates for natural and evolved enzymes used for the
selection of aptamers. Taq DNA polymerase has been used
to select a single-stranded DNA aptamer targeted to the
transforming growth factor-b1 (TGF-b1) where all dATPs
and dCTPs were substituted by phosphorothioates (Kang
et al., 2008). In another study, the M1 variant of Taq DNA
polymerase allowed the full substitution of dNTPs with
phosphorothioates (Ghadessy et al., 2004). Regarding less
frequent modifications, T7 RNA polymerase was used to select
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an ATP-binding aptamer containing 5′-(α-P-borano)-GTP and
5′-(α-P-borano)-UTP (Lato et al., 2002) and a mutated Pfu DNA
polymerase was able to incorporate nucleotides bearing a bulky
γ-phosphate-O-linker-dabcyl substituent (Hansen et al., 2011).
CONCLUSIONS AND PERSPECTIVES
The vast number and types of applications that modified
functional oligonucleotides offer to different fields such as
diagnosis, therapy, analytical chemistry, target validation and
molecular biology, makes of the use of modified nucleoside
triphosphates for in vitro selection techniques a challenging
research area. This strategy brings about a second generation of
functional oligonucleotides with higher nuclease resistance and
increased structural and chemical diversity allowing the selection
of molecules with differential properties respect to the natural
DNA or RNA oligomers such as improved binding or catalytic
activities. In addition, other benefits such as better uptake for in
vivo applications are expected.
Still many contributions and new developments are needed
mainly from two disciplines: molecular biology and organic
chemistry. The first one should generate a larger repertoire
of evolved polymerases able to faithfully recognize a wider
spectrum of modified nucleoside triphosphates. On the other
side, although chemistry already made available a plethora of
modified nucleosides, it still needs to provide a general and
efficient synthetic route tomodified nucleoside triphosphates and
to propose improvements of the current complex purification
protocols.
The research carried out in these areas, and summarized
in this review, indicates that in the near future these issues
will be successfully addressed expanding the scope of functional
oligonucleotides as useful custom-made tools for in vivo and in
vitro applications.
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